The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...
Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback